Task: Answer the multiple choice question.
Query: Which drug exhibits a -4.119% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1ccc(C(=O)Nc2cc(C(C)C)c(O)c(C(C)C)c2)cc1
b.) O=S(=O)(c1ccc(Cl)cc1)N1CCN2CCCC2C1
Answer: a. Cc1ccc(C(=O)Nc2cc(C(C)C)c(O)c(C(C)C)c2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)Nc2cc(C(C)C)c(O)c(C(C)C)c2)cc1
Cc1ccc(C(=O)Nc2cc(C(C)C)c(O)c(C(C)C)c2)cc1
N-[4-hydroxy-3,5-di(propan-2-yl)phenyl]-4-methylbenzamide